Loading…

Multiple focal nodular hyperplasia: MRI features

To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs). 40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH. 130 lesions were evaluated....

Full description

Saved in:
Bibliographic Details
Published in:Clinical imaging 2018-05, Vol.49, p.89-96
Main Authors: Busireddy, Kiran K., Ramalho, Miguel, AlObaidy, Mamdoh, Matos, António P., Burke, Lauren M., Dale, Brian M., Semelka, Richard C.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43
cites cdi_FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43
container_end_page 96
container_issue
container_start_page 89
container_title Clinical imaging
container_volume 49
creator Busireddy, Kiran K.
Ramalho, Miguel
AlObaidy, Mamdoh
Matos, António P.
Burke, Lauren M.
Dale, Brian M.
Semelka, Richard C.
description To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs). 40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH. 130 lesions were evaluated. The majority (88.5%), were peripheral in location. 92.3% lesions were lobulated. Marked enhancement was present in 94.6% lesions. In the portal venous and delayed phase, 46.2% and 47.7% lesions were mildly hyperintense. Central scar was present in 77% lesions. Distinctive features included predominant subcapsular location and mild hyperintensity in the delayed phase, seen in nearly 50% of FNHs. •This is the first series description of multiple FNHs by MRI.•The appearance of FNHs in the setting of multiple FNHs is comparable to that of solitary FNHs.•The majority of lesions were subcapsular in location.•Mild hyperintensity was seen in the interstitial phase in near 50% of the lesions.•Fatty FNHs were not uncommon and were seen in 11.5% of lesions.
doi_str_mv 10.1016/j.clinimag.2017.11.010
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1971639224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0899707117302413</els_id><sourcerecordid>2037416877</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43</originalsourceid><addsrcrecordid>eNqFkE1P3DAURS1EBQPtXxhFYsMmqZ-dxDYrECofEqhSBWvLsV_AI0-S2gnS_PtmNDNdsGH1Nufe-3QIWQItgEL9c1XY4Du_Nm8FoyAKgIICPSILkILnZanUMVlQqVQuqIBTcpbSis5BVYoTcsoUKFqBXBD6PIXRDwGztrcmZF3vpmBi9r4ZMA7BJG-usuc_j1mLZpwipu_kW2tCwh_7e05e73693D7kT7_vH29vnnLLVT3mDZMVM6jqSrWNqSUvmZRGNcxYJ4FZZ3jlWhS0tI7XCNI4iU1FWdW0gpuSn5PLXe8Q-78TplGvfbIYgumwn5IGJaDmirEtevEJXfVT7ObvNKNclFBLIWaq3lE29ilFbPUQZ39xo4HqrVO90geneutUA-jZ6Rxc7uunZo3uf-wgcQaudwDOPj48Rp2sx86i8xHtqF3vv9r4B4aKidE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2037416877</pqid></control><display><type>article</type><title>Multiple focal nodular hyperplasia: MRI features</title><source>ScienceDirect Freedom Collection</source><creator>Busireddy, Kiran K. ; Ramalho, Miguel ; AlObaidy, Mamdoh ; Matos, António P. ; Burke, Lauren M. ; Dale, Brian M. ; Semelka, Richard C.</creator><creatorcontrib>Busireddy, Kiran K. ; Ramalho, Miguel ; AlObaidy, Mamdoh ; Matos, António P. ; Burke, Lauren M. ; Dale, Brian M. ; Semelka, Richard C.</creatorcontrib><description>To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs). 40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH. 130 lesions were evaluated. The majority (88.5%), were peripheral in location. 92.3% lesions were lobulated. Marked enhancement was present in 94.6% lesions. In the portal venous and delayed phase, 46.2% and 47.7% lesions were mildly hyperintense. Central scar was present in 77% lesions. Distinctive features included predominant subcapsular location and mild hyperintensity in the delayed phase, seen in nearly 50% of FNHs. •This is the first series description of multiple FNHs by MRI.•The appearance of FNHs in the setting of multiple FNHs is comparable to that of solitary FNHs.•The majority of lesions were subcapsular in location.•Mild hyperintensity was seen in the interstitial phase in near 50% of the lesions.•Fatty FNHs were not uncommon and were seen in 11.5% of lesions.</description><identifier>ISSN: 0899-7071</identifier><identifier>EISSN: 1873-4499</identifier><identifier>DOI: 10.1016/j.clinimag.2017.11.010</identifier><identifier>PMID: 29190518</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Abdomen ; Adolescent ; Adult ; Aged ; Confidence intervals ; Contrast agents ; Contrast Media ; FDA approval ; Female ; Females ; FNH ; Focal Nodular Hyperplasia - diagnostic imaging ; Gangrene ; Hepatobiliary contrast agents ; Humans ; Hyperplasia ; Lesions ; Liver ; Liver - diagnostic imaging ; Magnetic Resonance Imaging ; Male ; Middle Aged ; MRI ; Multiple nodular focal hyperplasias ; NMR ; Nuclear magnetic resonance ; Portal Vein - diagnostic imaging ; Retrospective Studies ; Studies ; Telangiectatic ; Tumors ; Young Adult</subject><ispartof>Clinical imaging, 2018-05, Vol.49, p.89-96</ispartof><rights>2017</rights><rights>Copyright © 2017. Published by Elsevier Inc.</rights><rights>Copyright Elsevier Limited May 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43</citedby><cites>FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43</cites><orcidid>0000-0002-9081-0087</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29190518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Busireddy, Kiran K.</creatorcontrib><creatorcontrib>Ramalho, Miguel</creatorcontrib><creatorcontrib>AlObaidy, Mamdoh</creatorcontrib><creatorcontrib>Matos, António P.</creatorcontrib><creatorcontrib>Burke, Lauren M.</creatorcontrib><creatorcontrib>Dale, Brian M.</creatorcontrib><creatorcontrib>Semelka, Richard C.</creatorcontrib><title>Multiple focal nodular hyperplasia: MRI features</title><title>Clinical imaging</title><addtitle>Clin Imaging</addtitle><description>To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs). 40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH. 130 lesions were evaluated. The majority (88.5%), were peripheral in location. 92.3% lesions were lobulated. Marked enhancement was present in 94.6% lesions. In the portal venous and delayed phase, 46.2% and 47.7% lesions were mildly hyperintense. Central scar was present in 77% lesions. Distinctive features included predominant subcapsular location and mild hyperintensity in the delayed phase, seen in nearly 50% of FNHs. •This is the first series description of multiple FNHs by MRI.•The appearance of FNHs in the setting of multiple FNHs is comparable to that of solitary FNHs.•The majority of lesions were subcapsular in location.•Mild hyperintensity was seen in the interstitial phase in near 50% of the lesions.•Fatty FNHs were not uncommon and were seen in 11.5% of lesions.</description><subject>Abdomen</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Confidence intervals</subject><subject>Contrast agents</subject><subject>Contrast Media</subject><subject>FDA approval</subject><subject>Female</subject><subject>Females</subject><subject>FNH</subject><subject>Focal Nodular Hyperplasia - diagnostic imaging</subject><subject>Gangrene</subject><subject>Hepatobiliary contrast agents</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Lesions</subject><subject>Liver</subject><subject>Liver - diagnostic imaging</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Middle Aged</subject><subject>MRI</subject><subject>Multiple nodular focal hyperplasias</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Portal Vein - diagnostic imaging</subject><subject>Retrospective Studies</subject><subject>Studies</subject><subject>Telangiectatic</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>0899-7071</issn><issn>1873-4499</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkE1P3DAURS1EBQPtXxhFYsMmqZ-dxDYrECofEqhSBWvLsV_AI0-S2gnS_PtmNDNdsGH1Nufe-3QIWQItgEL9c1XY4Du_Nm8FoyAKgIICPSILkILnZanUMVlQqVQuqIBTcpbSis5BVYoTcsoUKFqBXBD6PIXRDwGztrcmZF3vpmBi9r4ZMA7BJG-usuc_j1mLZpwipu_kW2tCwh_7e05e73693D7kT7_vH29vnnLLVT3mDZMVM6jqSrWNqSUvmZRGNcxYJ4FZZ3jlWhS0tI7XCNI4iU1FWdW0gpuSn5PLXe8Q-78TplGvfbIYgumwn5IGJaDmirEtevEJXfVT7ObvNKNclFBLIWaq3lE29ilFbPUQZ39xo4HqrVO90geneutUA-jZ6Rxc7uunZo3uf-wgcQaudwDOPj48Rp2sx86i8xHtqF3vv9r4B4aKidE</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Busireddy, Kiran K.</creator><creator>Ramalho, Miguel</creator><creator>AlObaidy, Mamdoh</creator><creator>Matos, António P.</creator><creator>Burke, Lauren M.</creator><creator>Dale, Brian M.</creator><creator>Semelka, Richard C.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9081-0087</orcidid></search><sort><creationdate>201805</creationdate><title>Multiple focal nodular hyperplasia: MRI features</title><author>Busireddy, Kiran K. ; Ramalho, Miguel ; AlObaidy, Mamdoh ; Matos, António P. ; Burke, Lauren M. ; Dale, Brian M. ; Semelka, Richard C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abdomen</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Confidence intervals</topic><topic>Contrast agents</topic><topic>Contrast Media</topic><topic>FDA approval</topic><topic>Female</topic><topic>Females</topic><topic>FNH</topic><topic>Focal Nodular Hyperplasia - diagnostic imaging</topic><topic>Gangrene</topic><topic>Hepatobiliary contrast agents</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Lesions</topic><topic>Liver</topic><topic>Liver - diagnostic imaging</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Middle Aged</topic><topic>MRI</topic><topic>Multiple nodular focal hyperplasias</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Portal Vein - diagnostic imaging</topic><topic>Retrospective Studies</topic><topic>Studies</topic><topic>Telangiectatic</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Busireddy, Kiran K.</creatorcontrib><creatorcontrib>Ramalho, Miguel</creatorcontrib><creatorcontrib>AlObaidy, Mamdoh</creatorcontrib><creatorcontrib>Matos, António P.</creatorcontrib><creatorcontrib>Burke, Lauren M.</creatorcontrib><creatorcontrib>Dale, Brian M.</creatorcontrib><creatorcontrib>Semelka, Richard C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Busireddy, Kiran K.</au><au>Ramalho, Miguel</au><au>AlObaidy, Mamdoh</au><au>Matos, António P.</au><au>Burke, Lauren M.</au><au>Dale, Brian M.</au><au>Semelka, Richard C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple focal nodular hyperplasia: MRI features</atitle><jtitle>Clinical imaging</jtitle><addtitle>Clin Imaging</addtitle><date>2018-05</date><risdate>2018</risdate><volume>49</volume><spage>89</spage><epage>96</epage><pages>89-96</pages><issn>0899-7071</issn><eissn>1873-4499</eissn><abstract>To describe MRI features of multiple Focal Nodular Hyperplasia (FNHs). 40 consecutive subjects (37 females, mean age, 38.8years) were included. All studies were independently reviewed. This was an observational study to define the radiological features of multifocal FNH. 130 lesions were evaluated. The majority (88.5%), were peripheral in location. 92.3% lesions were lobulated. Marked enhancement was present in 94.6% lesions. In the portal venous and delayed phase, 46.2% and 47.7% lesions were mildly hyperintense. Central scar was present in 77% lesions. Distinctive features included predominant subcapsular location and mild hyperintensity in the delayed phase, seen in nearly 50% of FNHs. •This is the first series description of multiple FNHs by MRI.•The appearance of FNHs in the setting of multiple FNHs is comparable to that of solitary FNHs.•The majority of lesions were subcapsular in location.•Mild hyperintensity was seen in the interstitial phase in near 50% of the lesions.•Fatty FNHs were not uncommon and were seen in 11.5% of lesions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29190518</pmid><doi>10.1016/j.clinimag.2017.11.010</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9081-0087</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0899-7071
ispartof Clinical imaging, 2018-05, Vol.49, p.89-96
issn 0899-7071
1873-4499
language eng
recordid cdi_proquest_miscellaneous_1971639224
source ScienceDirect Freedom Collection
subjects Abdomen
Adolescent
Adult
Aged
Confidence intervals
Contrast agents
Contrast Media
FDA approval
Female
Females
FNH
Focal Nodular Hyperplasia - diagnostic imaging
Gangrene
Hepatobiliary contrast agents
Humans
Hyperplasia
Lesions
Liver
Liver - diagnostic imaging
Magnetic Resonance Imaging
Male
Middle Aged
MRI
Multiple nodular focal hyperplasias
NMR
Nuclear magnetic resonance
Portal Vein - diagnostic imaging
Retrospective Studies
Studies
Telangiectatic
Tumors
Young Adult
title Multiple focal nodular hyperplasia: MRI features
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T03%3A09%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20focal%20nodular%20hyperplasia:%20MRI%20features&rft.jtitle=Clinical%20imaging&rft.au=Busireddy,%20Kiran%20K.&rft.date=2018-05&rft.volume=49&rft.spage=89&rft.epage=96&rft.pages=89-96&rft.issn=0899-7071&rft.eissn=1873-4499&rft_id=info:doi/10.1016/j.clinimag.2017.11.010&rft_dat=%3Cproquest_cross%3E2037416877%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c396t-b2852ae9659fba6834288a9b2acd812cda35dfe704cd36e18ad8eb5025bf73a43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2037416877&rft_id=info:pmid/29190518&rfr_iscdi=true